Organon & Return on Equity (ROE) Growth & History (OGN)
Organon &'s return on equity was 30.56% for fiscal 2025.
View full Organon & company overviewOrganon & annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 30.56% | −399.30 pp |
| 2024 | 2024-12-31 | 429.85% | — |
| 2021 | 2021-12-31 | 67.92% | +33.42 pp |
| 2020 | 2020-12-31 | 34.50% | — |
Organon & quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 11.31% | −11.43 pp |
| Q1 2026 | 2026-03-31 | 17.64% | +0.48 pp |
| Q4 2025 | 2025-12-31 | −24.73% | −47.32 pp |
| Q3 2025 | 2025-09-30 | 19.52% | −93.19 pp |
| Q2 2025 | 2025-06-30 | 22.75% | −180.38 pp |
| Q1 2025 | 2025-03-31 | 17.16% | — |
| Q4 2024 | 2024-12-31 | 22.59% | — |
| Q3 2024 | 2024-09-30 | 112.72% | — |
| Q2 2024 | 2024-06-30 | 203.13% | — |
| Q2 2021 · Jun 30 | 2021-06-30 | 30.63% | — |
| Q1 2021 | 2021-03-31 | 7.82% | — |
| Q4 2020 | 2020-12-31 | 5.88% | — |
Organon & return on equity trends
Over the last five fiscal years, Organon &'s return on equity decreased from 34.50% to 30.56%, a change of −3.95 percentage points. The latest reported quarter, Q2 2026, shows 11.31%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Organon & source filings ↗